Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2020 Filed May 19, 2020 20:30 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001127602-20-017187 · form4.xml · derivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2020-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:30 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 267 | $72.41 | $19,333.47 |
DisclosureSEC source: 0001127602-20-017187 · form4.xml · nonDerivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,013 Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:30 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $19.26 | $19,260.00 |
DisclosureSEC source: 0001127602-20-017187 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:28 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001127602-20-017183 · form4.xml · derivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:28 UTC |
Cohen Heather LEVP CORP HR
|
Tax withholdingCommon Stock | 2,062 | $72.41 | $149,309.42 |
DisclosureSEC source: 0001127602-20-017183 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,328 Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:28 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 4,000 | $19.26 | $77,040.00 |
DisclosureSEC source: 0001127602-20-017183 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:19 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 112 | $54.41 | $6,093.92 |
DisclosureSEC source: 0001127602-20-012802 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:16 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012799 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:11 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012790 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:09 UTC |
Cohen Heather LEVP CORP HR
|
GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012788 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,390 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:00 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012778 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,629 Read SEC document |
| March 02, 2020 Filed Mar 2, 2020 21:03 UTC |
Workman John LDirector
|
PurchaseCommon Stock | 2,000 | $94.63 | $189,264.00 |
DisclosureSEC source: 0001127602-20-008558 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,035 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
GrantRsus (restricted Stock Units) · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · derivative · entry 8 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
GrantOptions To Purchase Common Stock · Derivative | 9,500 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · derivative · entry 7 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 9,500 shares Expires 2030-03-02 F3 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:50 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
GrantOptions To Purchase Common Stock · Derivative | 23,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · derivative · entry 4 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:47 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantOptions To Purchase Common Stock · Derivative | 31,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · derivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:43 UTC |
Hartman Curt RDirector · President & CEO
|
GrantOptions To Purchase Common Stock · Derivative | 205,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · derivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantOptions To Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
GrantOptions To Purchase Common Stock · Derivative | 12,750 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009023 · form4.xml · derivative · entry 4 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Stock · 12,750 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:32 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantOptions To Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009013 · form4.xml · derivative · entry 4 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:30 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantOptions To Purchase Common Stock · Derivative | 53,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · derivative · entry 4 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
GrantOptions To Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 7 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:24 UTC |
Cohen Heather LEVP CORP HR
|
GrantOptions To Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-008986 · form4.xml · derivative · entry 4 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:22 UTC |
Beyer PatPresident - International
|
GrantOptions To Purchase Common Stock · Derivative | 55,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-008979 · form4.xml · derivative · entry 4 Beyer Pat · CIK 0001627985 · President - International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:18 UTC |
Berge Terence MVP-Corporate Controller
|
GrantOptions To Purchase Common Stock · Derivative | 12,750 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-008972 · form4.xml · derivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Stock · 12,750 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · derivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 325 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · derivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 325 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 367 | $94.64 | $34,732.88 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 96 | $94.64 | $9,085.44 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,726 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:52 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009075 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Tax withholdingCommon Stock | 88 | $94.64 | $8,328.32 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Tax withholdingCommon Stock | 124 | $94.64 | $11,735.36 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:43 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · derivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:43 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009048 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 375 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Tax withholdingCommon Stock | 118 | $94.64 | $11,167.52 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Tax withholdingCommon Stock | 111 | $94.64 | $10,505.04 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009023 · form4.xml · derivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 62 | $94.64 | $5,867.68 |
DisclosureSEC source: 0001127602-20-009023 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,728 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009023 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:32 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009013 · form4.xml · derivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:32 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 175 | $94.64 | $16,562.00 |
DisclosureSEC source: 0001127602-20-009013 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,405 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.